Why isn’t this headline news? GlaxoSmithKline will have to cough up US$3bn to settle misdemeanour criminal charges in the largest case of healthcare fraud in US history.
The Guardian reported:
GSK targeted the antidepressant Paxil at patients under age 18 when it was approved only for adults, and promoted the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction, according to a US justice department investigation.
and in a yet another case:
In a third case, GSK failed to give the US Food and Drug Administration safety data about its diabetes drug Avandia, in violation of US law, prosecutors said.
Shows you, you can’t have blind faith in these fancy drugs.